Medicare Enrolled

Dr. Carsten Kampe, PHD,MD,FACP

Medical Oncology · Austin, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
4101 JAMES CASEY ST, Austin, TX 78745
5124472202
In practice since 2006 (19 years)
NPI: 1912944521 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kampe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kampe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kampe

Dr. Carsten Kampe is a medical oncology specialist in Austin, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kampe performed 11,025 Medicare services across 1,661 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kampe received a total of $142 from 5 pharmaceutical and/or device companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kampe is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 40% volume in TX $142 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,025
Medicare services
Top 40% in TX for medical oncology
1,661
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~580 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging (iodine-based) 6,985 $0 $3
Blood draw (venipuncture) 583 $8 $20
Dexamethasone injection (steroid) 461 $0 $1
Complete blood count (CBC) with differential 374 $8 $36
Comprehensive metabolic blood panel 367 $10 $64
Office visit, established patient (30-39 min) 341 $93 $368
Immunoglobulin level test 186 $9 $56
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session 133 $301 $2,762
Office visit, established patient, complex (40-54 min) 131 $137 $496
Lactate dehydrogenase (enzyme) level 91 $6 $31
Measurement of immunoglobulin light chains 88 $17 $60
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 84 $24 $157
Ferritin level test (iron stores) 73 $13 $60
Iron level test 73 $6 $27
Iron binding capacity test 73 $9 $35
Administration of chemotherapy into vein, 1 hour or less 65 $108 $707
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 63 $20 $128
Ct scan of chest with contrast 56 $51 $821
Microscopic examination for white blood cells with manual cell count 56 $4 $22
Complete blood count (CBC), automated 56 $6 $34
Injection of additional new drug or substance into vein 56 $13 $108
Carcinoembryonic antigen (cea) protein level 55 $18 $99
Hospital follow-up visit, moderate complexity 52 $61 $247
Magnesium level test 47 $7 $29
CT scan of abdomen and pelvis with contrast 46 $182 $1,067
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev 43 $196 $700
Infusion, normal saline solution , 1000 cc 43 $2 $19
New patient office visit, complex (60-74 min) 40 $169 $709
Thyroid stimulating hormone (TSH) test 30 $16 $80
Reticulated (young) platelet measurement 29 $34 $143
New patient office visit (45-59 min) 28 $127 $565
Protein measurement, serum 24 $11 $99
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 23 $17 $100
Hospital follow-up visit, high complexity 22 $94 $357
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg 21 $404 $1,722
Administration of additional new drug or substance into vein, 1 hour or less 20 $53 $344
Infusion into a vein for hydration, each additional hour 17 $10 $75
Administration of chemotherapy into vein, each additional hour 17 $23 $161
Injection, diphenhydramine hcl, up to 50 mg 17 $1 $7
Drug injection, under skin or into muscle 15 $11 $96
Office visit, established patient (20-29 min) 15 $71 $250
Ct scan of soft tissue of neck with contrast 14 $73 $658
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 12 $53 $313
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
70.7% medium
27.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$142
Total received (2019-2024)
Avg $36/year across 4 years
Bottom 10% in TX for medical oncology
5
Companies
7
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$130 (91.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (8.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$72
2021
$40
2020
$13
2019
$18

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$65
Amgen Inc.
$28
Myriad Genetic Laboratories, Inc.
$21
Celgene Corporation
$16
Gilead Sciences, Inc.
$12
Top 3 companies account for 80.3% of total payments
Associated products mentioned in payments ›
DARZALEX · ERLEADA · IMBRUVICA · MYRISK · Otezla · REBLOZYL
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1 per 100 Medicare services performed
Looking for a medical oncology specialist in Austin?
Compare medical oncologists in the Austin area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
25
Per 100K population
1.9
County median income
$97,169
Nearest hospital
AUSTIN OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kampe is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kampe experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Kampe performed 6,985 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kampe receive payments from pharmaceutical companies?
Yes. Dr. Kampe received a total of $142 from 5 companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kampe's costs compare to other medical oncologists in Austin?
Dr. Kampe's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kampe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →